These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3731102)

  • 21. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytocidal activity of a synthetic isoprenoid, N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine, and its potentiation of antitumor drugs against multidrug-resistant and sensitive cells in vitro.
    Suzuki H; Tomida A; Nishimura T
    Jpn J Cancer Res; 1990 Mar; 81(3):298-303. PubMed ID: 2161816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro characterization of S9788, a new modulator of multidrug resistance].
    Pérez V; Pierré A; Léonce S; Anstett M; Prost JF; Atassi G
    Bull Cancer; 1993 Apr; 80(4):310-25. PubMed ID: 8173185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of P-glycoprotein-mediated paclitaxel resistance by new synthetic isoprenoids in human bladder cancer cell line.
    Enokida H; Gotanda T; Oku S; Imazono Y; Kubo H; Hanada T; Suzuki S; Inomata K; Kishiye T; Tahara Y; Nishiyama K; Nakagawa M
    Jpn J Cancer Res; 2002 Sep; 93(9):1037-46. PubMed ID: 12359058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance.
    Coon JS; Knudson W; Clodfelter K; Lu B; Weinstein RS
    Cancer Res; 1991 Feb; 51(3):897-902. PubMed ID: 1988130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Markedly altered membrane transport and intracellular binding of vincristine in multidrug-resistant Chinese hamster cells selected for resistance to vinca alkaloids.
    Sirotnak FM; Yang CH; Mines LS; Oribé E; Biedler JL
    J Cell Physiol; 1986 Feb; 126(2):266-74. PubMed ID: 3944208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysosomotropic agents reverse multiple drug resistance in human cancer cells.
    Shiraishi N; Akiyama S; Kobayashi M; Kuwano M
    Cancer Lett; 1986 Mar; 30(3):251-9. PubMed ID: 3697945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype.
    Mi Q; Cui B; Silva GL; Lantvit D; Lim E; Chai H; You M; Hollingshead MG; Mayo JG; Kinghorn AD; Pezzuto JM
    Cancer Res; 2001 May; 61(10):4030-7. PubMed ID: 11358822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.
    Barthomeuf C; Grassi J; Demeule M; Fournier C; Boivin D; Béliveau R
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):173-81. PubMed ID: 15824923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of 2-chloro-N10-substituted phenoxazines for reversing multidrug resistance in cancer cells.
    Thimmaiah KN; Jayashree BS; Germain GS; Houghton PJ; Horton JK
    Oncol Res; 1998; 10(1):29-41. PubMed ID: 9613455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of vindesine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-alpha.
    Licht T; Lübbert M; Martens C; Bross KJ; Fiebig HH; Mertelsmann R; Herrmann F
    Cytokines Mol Ther; 1995 Jun; 1(2):123-32. PubMed ID: 9384669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract.
    Limtrakul P; Khantamat O; Pintha K
    Cancer Chemother Pharmacol; 2004 Dec; 54(6):525-30. PubMed ID: 15248030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells.
    Lavie Y; Harel-Orbital T; Gaffield W; Liscovitch M
    Anticancer Res; 2001; 21(2A):1189-94. PubMed ID: 11396162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1p31, 7q21 and 18q21 chromosomal aberrations and candidate genes in acquired vinblastine resistance of human cervical carcinoma KB cells.
    Wang J; Tai LS; Tzang CH; Fong WF; Guan XY; Yang M
    Oncol Rep; 2008 May; 19(5):1155-64. PubMed ID: 18425371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
    Kumar A; Soprano DR; Parekh HK
    Cancer Res; 2001 Oct; 61(20):7552-5. PubMed ID: 11606393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of multidrug resistance by synthetic and natural compounds in drug-resistant MCF-7 cell lines.
    Kars MD; Işeri OD; Gunduz U; Molnar J
    Chemotherapy; 2008; 54(3):194-200. PubMed ID: 18560226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Stemona curtisii root extract on P-glycoprotein and MRP-1 function in multidrug-resistant cancer cells.
    Limtrakul P; Siwanon S; Yodkeeree S; Duangrat C
    Phytomedicine; 2007 Jun; 14(6):381-9. PubMed ID: 17467965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of multidrug resistance (MDR1) P-glycoprotein expression levels and coordination metal on the cytotoxic potency of multidentate (N4O2) (ethylenediamine)bis[propyl(R-benzylimino)]metal(III) cations.
    Sharma V; Crankshaw CL; Piwnica-Worms D
    J Med Chem; 1996 Aug; 39(18):3483-90. PubMed ID: 8784446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced potency of daunorubicin against multidrug resistant subline KB-ChR-8-5-11 by a pulsed magnetic field.
    Liang Y; Hannan CJ; Chang BK; Schoenlein PV
    Anticancer Res; 1997; 17(3C):2083-8. PubMed ID: 9216668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effects of a novel marine terpenoid on sensitive and multidrug resistant KB cell lines.
    Pec MK; Hellan M; Moser-Thier K; Fernández JJ; Souto ML; Kubista E
    Anticancer Res; 1998; 18(4C):3027-32. PubMed ID: 9713504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.